Vor Biopharma (NasdaqGS:VOR) Update / Briefing Transcript

Vor Biopharma (NasdaqGS:VOR) Update / Briefing October 28, 2025 04:30 PM ET Speaker2Good afternoon, everyone, and welcome to the Vor Bio conference call discussing the telitacicept China Phase 3 short-term results. At this time, all participants are in listen-only mode. There will be a question-and-answer session to follow. I would like to introduce the company.Speaker4Thank you, and good afternoon, everyone, on the call. Earlier today, our collaborator, RemeGen, presented a late-breaking poster at ACR Conv ...